Effectiveness of emicizumab in preventing bleeding events in hemophilia A patients: An observational study

Effectiveness of emicizumab in preventing bleeding events in hemophilia A patients: An observational study

Saved in:

Bibliographic Details
Main Authors:	Nikhil Gupta, Mousin Mustafa Batt, Amit Saini, Sanjeev Kumar Digra
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124524001578
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Outcomes of Emicizumab in Acquired Hemophilia Patients: A Systematic Review
by: Ghachem Ikbel MD, et al.
Published: (2024-11-01)

Evaluation of Safety and Efficacy of Emicizumab Prophylaxis in Egyptian Pediatric Patients with Hemophilia A
by: Tamer Hassan, et al.
Published: (2024-12-01)

Enteric fever with heart block in pediatric patients: A rare but serious complication
by: Twinkle Gupta, et al.
Published: (2024-01-01)

Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center
by: Qianqian Mao, et al.
Published: (2024-12-01)

No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy
by: Konrad van der Zwet, et al.
Published: (2025-01-01)

Emicizumab in two patients with acquired haemophilia A – case report
by: Zhao Milly, et al.
Published: (2024-08-01)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
by: Raffaele De Caterina, et al.
Published: (2019-03-01)

Work adjustments for patients with hemophilia
by: Negin Kassiri, et al.
Published: (2024-11-01)

ID256 Análise de desempenho do emicizumabe no tratamento da hemofilia a no brasil: resultados do primeiro ano de acompanhamento do registro brasileiro de emicizumabe (Projeto EMCase)
by: Juliana Alvares-Teodoro, et al.
Published: (2024-11-01)

HINODE study: haemophilia A in infancy and newborns – protocol for a prospective, multicentre, observational study evaluating the coagulation potential and safety of emicizumab prophylaxis
by: Shouichi Ohga, et al.
Published: (2024-12-01)

Treatment and prevention of arresive bleeding in patients with pancreonecrosis.
by: V. V. Boyko, et al.
Published: (2018-12-01)

Single-center experience on rare inherited bleeding disorders other than hemophilia and von willebrand disease in south indian children
by: Brundavanam Venkata Krishna Sai
Published: (2024-01-01)

Investigation of SEN virus prevalence in hemophilia patients
by: Davod Javanmard, et al.
Published: (2024-12-01)

Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study
by: Christian Herbert Burgmann, et al.
Published: (2024-10-01)

HEMOPHILIA: ADVANCES IN TREATMENTS
by: Nurgül Karakaya
Published: (2024-12-01)

MANAGEMENT OF INHIBITORS IN HEMOPHILIA
by: Gaye Kalacı Katayıfçı
Published: (2024-12-01)

Gene therapy for hemophilia
by: Peter J. Lenting, et al.
Published: (2024-12-01)

To determine the prevalence and patterns of side effects of chemotherapy in children with acute lymphoblastic leukemia
by: Sunali Jamwal, et al.
Published: (2024-01-01)

Intracranial hemorrhage before start of prophylaxis in children with hemophilia: incidence, timing, and potential for prevention
by: Nadine G. Andersson, et al.
Published: (2024-11-01)

Lower Gastrointestinal Bleeding in Chronic Hemodialysis Patients
by: Fahad Saeed, et al.
Published: (2011-01-01)

Estimating the prevalence of vitamin B12 and vitamin D deficiency in children with thalassemia major
by: Abhishek Chambial, et al.
Published: (2024-01-01)

Circumcision of Hemophilia Patients: Hematological and Socio-Cultural Aspect
by: Goksel leblebisatan, et al.
Published: (2014-08-01)

Advances in biopharmaceutical products for hemophilia
by: Junzheng Wu, et al.
Published: (2024-12-01)

Editorial: Severe bleeding events among critically ill patients with hematological malignancies
by: Nathan D. Nielsen, et al.
Published: (2024-11-01)

A case report on a patient with acute lymphoblastic leukaemia, with unusual side effects, using the intravenous route for administration of cytarabine versus the subcutaneous route
by: Aadarshita Verma, et al.
Published: (2024-01-01)

A single centre experience with clinical use of Neria™ Guard as mode of pain and distress management in the administration of emicizumab in children
by: Birkedal Maj Friberg
Published: (2024-12-01)

Occurrence and Impact of Gastrointestinal Bleeding and Major Adverse Cardiovascular Events during Sepsis: A 15-Year Observational Study
by: Ming-Shun Hsieh, et al.
Published: (2020-01-01)

Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study
by: Mizoguchi Y, et al.
Published: (2025-01-01)

Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study
by: Shyh-Shin Chiou, et al.
Published: (2024-11-01)

Hemophilia A Complicated by Ulcerative Colitis
by: Maxim Olivier, et al.
Published: (2018-01-01)

Hemophilia A Haplotypes in Southwestern Iran
by: Bizhen Keikhaei Dehdezi, et al.
Published: (2025-01-01)

MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA
by: Davide Matino, et al.
Published: (2020-01-01)

Total Hip Arthroplasty for Avascular Necrosis in a Patient With Hemophilia B
by: Siddhartha Dandamudi, BBA, et al.
Published: (2024-12-01)

Role of the Hemostasis and Thrombosis Unit in the Management of Patients with Acquired Hemophilia A
by: Antonella Mameli, et al.
Published: (2024-12-01)

Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary
by: Carmen Escuriola Ettingshausen, et al.
Published: (2024-11-01)

Risk of postoperative bleeding and thromboembolic events in anticoagulated patients undergoing transurethral resection of bladder tumors
by: Thomas Paul Scherer, et al.
Published: (2025-02-01)

AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION
by: Pier Mannuccio Mannucci
Published: (2019-08-01)

Acquired Hemophilia A successfully treated with rituximab
by: Giovanni D'Arena, et al.
Published: (2015-02-01)

The changing landscape of treatment for acquired hemophilia A
by: Massimo Franchini, et al.
Published: (2025-01-01)

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study
by: Vicki Osborne, et al.
Published: (2020-11-01)